February 21, 2024 · Form 4 insider transaction
Cannon Kara bought 10,640 shares of Enzo Biochem at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 6 days after the transaction.
Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.